Studies immune responses in patients treated for acute ischemic stroke
Observes immune and inflammatory changes in adults after clot removal for stroke.
Plain-language title generated from the registry record
Registry title: IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy (IMPRESS)
Key facts
- Where
- Paris, FranceSee the site
Where in France
- Hopital Fondation Adolphe de RothschildParis, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondation Ophtalmologique Adolphe de Rothschild
- Trial code
- NCT04663399
- Record updated
- 23 January 2026
- Original description
IMPRESS study aims to describe the immuno-inflammatory and thrombo-inflammatory profiles during the first 24/36 hours of treatment of patients suffering from AIC treated with TM, and to study the possible impact of these profiles on the functional prognosis at 3 and 12 months of AIC treatment.Read full original descriptionShow less
IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy
IMPRESS study aims to describe the immuno-inflammatory and thrombo-inflammatory profiles during the first 24/36 hours of treatment of patients suffering from AIC treated with TM, and to study the possible impact of these profiles on the functional prognosis at 3 and 12 months of AIC treatment.
Inclusion: Patient with an acute ischemic stroke for which treatment with mechanical thrombectomy is indicated, whether or not thrombectomy is performed,; Having received informed information about the study and having signed a consent to participate in the study (if this is not possible: information and consent of the trusted support person or family member if present; emergency inclusion if absent); Affiliated or beneficiary of a social security scheme or equivalent; Non inclusion Criteria:; Pregnant or breast-feeding women; Patient benefiting from a legal protection measure.
Exclusion: None.